1. Tumefactive demyelination in MOG Ab-associated disease, multiple sclerosis, and AQP-4-IgG-positive neuromyelitis optica spectrum disorder;Cacciaguerra;Neurology,2023
2. Multiple sclerosis with atypical MRI presentation: results of a nationwide multicenter study in 57 consecutive cases;Codjia;Mult. Scler. Relat. Disord.,2019
3. Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States;Fereidan-Esfahani;Eur. J. Neurol.,2022
4. Cyclophosphamide in treatment of tumefactive multiple sclerosis;Fereidan-Esfahani;Mult. Scler. Relat. Disord.,2021
5. Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis;Kalinowska-Lyszczarz;Mult. Scler.,2022